← Back to Search

Counseling for Suicide

N/A
Recruiting
Led By Marie V Soller, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
OHSU medical residents, fellows, and full-time School of Medicine faculty
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time of intake to participants' end of treatment or 6 months since last seen
Awards & highlights

Study Summary

This trial is testing whether an anonymous online screening for stress, depression, substance use, and suicidal thoughts will help medical trainees and faculty who are in distress. It is expected that the screening will make them more likely to come for counseling and that their suicide risk factors will be lower after they receive treatment.

Who is the study for?
This trial is for OHSU medical residents, fellows, and full-time School of Medicine faculty who may be experiencing stress, depression, substance use issues, or suicidal thoughts. The goal is to see if anonymous online screening can encourage them to seek in-person counseling.Check my eligibility
What is being tested?
The study tests an online interactive screening tool designed to identify distress signs like depression and suicidal thoughts among medical professionals. It aims to determine if this approach increases their likelihood of pursuing further counseling.See study design
What are the potential side effects?
Since the intervention involves counseling without medication or invasive procedures, no direct physical side effects are expected. However, discussing sensitive topics might cause temporary emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time of intake to participants' end of treatment or 6 months since last seen
This trial's timeline: 3 weeks for screening, Varies for treatment, and time of intake to participants' end of treatment or 6 months since last seen for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Demographics of residents and faculty physicians who seek counseling through in house program
ISP levels of distress seen with medical trainees and faculty
Who responds to treatment--level of distress
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CounselingExperimental Treatment1 Intervention
in-person counseling through RFWP to distressed respondents on the ISP and patients who seek counseling without completing the ISP
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
counseling
2007
Completed Phase 3
~1580

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
980 Previous Clinical Trials
7,382,722 Total Patients Enrolled
2 Trials studying Suicide
394 Patients Enrolled for Suicide
Marie V Soller, MDPrincipal InvestigatorOregon Health and Science University
Sydney S Ey, Ph.D.Principal InvestigatorOregon Health and Science University
~1493 spots leftby Oct 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top